Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Invivo Therapeutics Holdings Corp (NVIV)

Invivo Therapeutics Holdings Corp (NVIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivo Therapeutics Holdings Corp ONE KENDALL SQUARE SUITE B14402 CAMBRIDGE MA 02139 USA

P: 617-863-5500

Description:

InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 11,102
Enterprise Value, $K -7,928
Shares Outstanding, K 1,391
Annual Sales, $ 0 K
Annual Net Income, $ -9,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,719 K
60-Month Beta 1.10
% of Insider Shareholders 0.63%
% of Institutional Shareholders 4.53%
Float, K 1,382
% Float 99.37%
Short Volume Ratio 0.39

Growth:

1-Year Return -67.94%
3-Year Return -97.71%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.94 on 05/10/22
Next Earnings Date 11/09/22
Earnings Per Share ttm -4.19
EPS Growth vs. Prev Qtr 13.78%
EPS Growth vs. Prev Year 3.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 04/27/22

NVIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.73%
Return-on-Assets % -53.72%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.47
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar